Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors

European Journal of Radiology

Volumn 61, Issue 1, 2007, Pages 163-169

  Okamoto, Yuko ^a   Kawamoto, Hirofumi ^a   Takaki, Akinobu ^a   Ishida, Etsuji ^a   Ogawa, Tsuneyoshi ^a   Kuwaki, Kenji ^a   Kobayashi, Yoshiyuki ^a   Sakaguchi, Kohsaku ^a   Shiratori, Yasushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Contrast enhanced ultrasonography; Levovist; Pancreatic tumors

Indexed keywords

COMPUTER AIDED DIAGNOSIS; COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; PATIENT TREATMENT; TUMORS;

CONTRAST-ENHANCED ULTRASONOGRAPHY; PANCREATIC TUMORS; TUMOR VESSELS;

ULTRASONIC IMAGING;

IOPAMIDOL; SHU 508;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULARIZATION; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 33845920996     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.08.014     Document Type: Article

References (25)

1. Rosewicz S., and Wiedenmann B. Pancreatic carcinoma. Lancet 349 9050 (1997) 485-489
2. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
3. DiMagno E.P., Reber H.A., and Tempero M.A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 117 6 (1999) 1464-1484
4. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 6 (1997) 2403-2413
5. Shore S., Raraty M.G., Ghaneh P., and Neoptolemos J.P. Review article: chemotherapy for pancreatic cancer. Aliment Pharmacol Ther 18 11/12 (2003) 1049-1069
6. Van Laethem J.L., Van Maele P., Verslype C., et al. Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study. Oncology 67 5/6 (2004) 338-343
7. McBride G. Researchers optimistic about targeted drugs for pancreatic cancer. J Natl Cancer Inst 96 21 (2004) 1570-1572
8. Kulig J., Popiela T., Zajac A., Klek S., and Kolodziejczyk P. The value of imaging techniques in the staging of pancreatic cancer. Surg Endosc (2004)
9. Jhala N.C., Jhala D., Eltoum I., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions. Cancer 102 4 (2004) 239-246
10. Tanaka S., Ioka T., Oshikawa O., Hamada Y., and Yoshioka F. Dynamic sonography of hepatic tumors. Am J Roentgenol 177 4 (2001) 799-805
11. Okanobu H., Hata J., Haruma K., et al. Preoperative assessment of gastric cancer vascularity by flash echo imaging. Scand J Gastroenterol 37 5 (2002) 608-612
12. Kitano M., Kudo M., Maekawa K., et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53 6 (2004) 854-859
13. Ohshima T., Yamaguchi T., Ishihara T., et al. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 28 3 (2004) 335-343
14. Takeda K., Goto H., Hirooka Y., et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol 44 1 (2003) 103-106
15. Oshikawa O., Tanaka S., Ioka T., et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. Am J Roentgenol 178 5 (2002) 1133-1137
16. Sofuni A., Iijima H., Moriyasu F., et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40 5 (2005) 518-525
17. Goldberg B.B., Liu J.B., Burns P.N., Merton D.A., and Forsberg F. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 12 8 (1993) 463-470
18. Kamiyama N., Moriyasu F., Mine Y., and Goto Y. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 25 3 (1999) 411-420
19. Scialpi M., Midiri M., Bartolotta T.V., et al. Pancreatic carcinoma versus chronic focal pancreatitis: contrast-enhanced power Doppler ultrasonography findings. Abdom Imaging 30 2 (2005) 222-227
20. Numata K., Ozawa Y., Kobayashi N., et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 40 6 (2005) 631-640
21. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 7 (1999) 527-543
22. Kurahara H., Takao S., Maemura K., et al. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res 10 24 (2004) 8413-8420
23. Kuwahara K., Sasaki T., Kuwada Y., et al. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 26 4 (2003) 344-349
24. Seo Y., Baba H., Fukuda T., Takashima M., and Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 88 10 (2000) 2239-2245
25. Masaki T., Ohkawa S., Amano A., et al. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 103 5 (2005) 1026-1035